Market Research Logo

Healthcare Global Market Report 2018Including: Healthcare Services; Pharmaceutical Drugs; Medical Equipment; BiologicCovering: NHS, Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG

Healthcare Global Market Report 2018Including: Healthcare Services; Pharmaceutical Drugs; Medical Equipment; BiologicCovering: NHS, Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG

The Healthcare Global Market Report provides strategists, marketers and senior management with the critical information they need to assess the global healthcare market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the healthcare? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider healthcare market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The healthcare market section of the report gives context. It compares the healthcare market with other segments of the healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Healthcare Market Indicators Comparison.
  • The industry metrics section looks at critical drivers while the macro-economic section looks at the market in relation to the overall economy.
Scope

Markets Covered: Healthcare Services; Pharmaceutical Drugs; Medical Equipment; Biologic

Companies Mentioned: NHS, Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Healthcare Market Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Healthcare Market Characteristics
2. Healthcare Market Size and Growth; 2.1. Historic Market Growth, Value ($ Billion); 2.1.1. Drivers of the Market; 2.1.1.1. I Health Insurance Reforms; 2.1.1.2. Falling Oil Prices; 2.1.1.3. Technology Development; 2.1.2. Restraints on the Market; 2.1.2.1. Patent Expiration of Drugs; 2.1.2.2. Low Healthcare Access; 2.1.2.3. Government Regulations; 2.1.2.4. Shortage Of Skilled Manpower; 2.2. Forecast Market Growth, Value ($ Billion); 2.2.1. Drivers of the Market; 2.2.1.1. Aging Populations; 2.2.1.2. Increase In Healthcare Access; 2.2.1.3. Economic Growth; 2.2.1.4. Changes in Lifestyles; 2.2.2. Restraints on the Market; 2.2.2.1. Rising Cost; 2.2.2.2. Reduction In Free Trade; 2.2.2.3. Self-Care Diagnostics; 2.2.2.4. Political Instability Driven By The Rise Of Authoritarian Rulers
3. Healthcare Market Trends And Strategies; 3.1. Digitalization Of Medical Records; 3.2. Shared Medical Appointments; 3.3. Personalized Health; 3.4. Increase in Mergers and Acquisitions
4. PESTLE Analysis; 4.1. Political; 4.2. Economic; 4.3. Social; 4.4. Technological; 4.5. Legal; 4.6. Environmental
5. Healthcare Market Customer Information
6. Healthcare Market Regional And Country Analysis; 6.1. Global Healthcare Market, 2017, By Region, Value ($ Billion); 6.2. Global Healthcare Market, 2013 - 2021, Historic And Forecast, By Region; 6.3. Global Healthcare Market, Growth And Market Share Comparison, By Region; 6.4. Healthcare Market, 2017, By Country, Value ($ Billion); 6.5. Healthcare Market, 2013 - 2021, Historic And Forecast, By Country; 6.6. Global Healthcare Market, Growth And Market Share Comparison, By Country
7. Healthcare Market Segmentation; 7.1. Global Healthcare Market, 2017, By Segment, Value ($ Billion); Healthcare Services; Pharmaceutical Drugs; Medical Equipment; Biologics; 7.2. Global Healthcare Market, 2013 - 2021, Historic and Forecast, By Segment; 7.3. Global Healthcare Market, Growth And Market Share Comparison, By Segment
8. Healthcare Market Segments; 8.1.1. Healthcare Services; a) Market Characteristics; b) Market Trends And Strategies; 1)Increase in Bundle Payments; 2)Digital Tools Usage; 3)More Power With Patients; 4)Collaborations Across Industries and Companies; c) Global Healthcare Services Market, 2017, By Segment, Value ($ Billion); 1)Hospitals and Outpatient Care Centers; 2)Physicians and Other Health Practitioners; 3)Home Health Care and Residential Nursing Care Services; 4)Dental Services; 5)Medical And Diagnostic Laboratory Services; 6)Residential Substance Abuse and Mental Health Facilities; 7)Veterinary Services; d) Global Healthcare Services Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Healthcare Services Market, Growth And Market Share Comparison, By Segment; 8.1.1.1. Hospitals and Outpatient Care Centers; a) Market Characteristics; b) Market Trends And Strategies; 1)Digitalization Of Medical Records; 2)Shared Medical Appointments; 3)Virtual care; 4)E-commerce Solutions; 5)Medical Tourism; c) Global Hospitals and Outpatient Care Centers Market, 2017, By Segment, Value ($ Billion); 1)Hospitals; 2)Outpatient Care Centers; d) Global Hospitals and Outpatient Care Centers Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Hospitals and Outpatient Care Centers Market, Growth And Market Share Comparison, By Segment; 8.1.1.2. Physicians and Other Health Practitioners; a) Market Characteristics; b) Market Trends And Strategies; 1) Digitalization of Medical Records; 2) Provision of Personalized Care; 3) Practice of E-prescribing; 4) Monitoring of Services; c) Global Physicians and Other Health Practitioners Market, 2017, By Segment, Value ($ Billion); 1) Specialist Doctors; 2) Primary Care Doctors; 3) Physical Therapists; 4) Optometrists; 5) Chiropractors; 6) Podiatrists; d) Global Physicians and Other Health Practitioners Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Physicians and Other Health Practitioners Market, Growth And Market Share Comparison, By Segment; 8.1.1.3. Home Health Care and Residential Nursing Care Services; a) Market Characteristics; b) Market Trends And Strategies; 1) Preventative Health Services; 2) Integrated Care Services; 3) Wearable Devices Increasingly Popular; c) Global Home Health Care and Residential Nursing Care Services Market, 2017, By Segment, Value ($ Billion); 1) Home Health Care Providers; 2) Nursing Care Facilities; 3) Orphanages & Group Homes; 4) Retirement Communities; d) Global Home Health Care and Residential Nursing Care Services Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Home Health Care and Residential Nursing Care Services Market, Growth And Market Share Comparison, By Segment; 8.1.1.4. Dental Services; a) Market Characteristics; b) Market Trends And Strategies; 1) Dental Service Organizations (DSOs); 2) Preference For Ceramics; 3) Adoption Of New Technology; 4) Decrease In Independent Dental Laboratories; c) Global Dental Services Market, 2017, By Segment, Value ($ Billion); 1) General Dentistry; 2) Oral Surgery; 3) Orthodontics And Prosthodontics; d) Global Dental Services Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Dental Services Market, Growth And Market Share Comparison, By Segment; 8.1.1.5. Medical And Diagnostic Laboratory Services; a) Market Characteristics; b) Market Trends And Strategies; 1) Wellness Diagnostics; 2) Epigenetics; 3) Printed Paper Diagnostics; 4) Point-of-Care Tests (POCTs); 5) Lab Consolidation and Automation; c) Global Medical And Diagnostic Laboratory Services Market, 2017, By Segment, Value ($ Billion); 1) Medical Laboratories; 2) Diagnostic Imaging Centers; d) Global Medical And Diagnostic Laboratory Services Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Medical And Diagnostic Laboratory Services Market, Growth And Market Share Comparison, By Segment; 8.1.1.6. Residential Substance Abuse and Mental Health Facilities; a) Market Characteristics; b) Market Trends And Strategies; 1) Online Treatment Services; 2) Medications and Therapies for Alcohol Use Disorders; 3) Recovery Support Services; 4) Increase In Implants, Stimulants and Biologics Usage; 5) Increase In Serotonin-Reuptake Inhibitors (SRIs) Prescription; c) Global Residential Substance Abuse and Mental Health Facilities Market, 2017, By Segment, Value ($ Billion); 1) Residential Mental Health & Intellectual Disability Facilities; 2) Substance Abuse Centers; d) Global Residential Substance Abuse and Mental Health Facilities Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Residential Substance Abuse and Mental Health Facilities Market, Growth And Market Share Comparison, By Segment; 8.1.1.7. Veterinary Services; a) Market Characteristics; b) Market Trends And Strategies; 1) Electronic Health Records; 2) Insurance Services Aiding Pet Owners; 3) Specialty Services; 4) Portable Technology; c) Global Hospitals and Outpatient Care Centers Market, 2017, By Segment, Value ($ Billion); 1) Animal Hospitals And Veterinary Clinics; 2) Veterinary Laboratory Testing Services; d) Global Hospitals and Outpatient Care Centers Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Hospitals and Outpatient Care Centers Market, Growth And Market Share Comparison, By Segment; 8.1.2. Pharmaceutical Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Early Rx-To-OTC Switch; 2) Demand For New Medicines For Drug-Resistant Infections; 3) Turning Away From Animal Testing; 4) Increase In Personalized Medicine; 5) Collaboration Driving Innovation; 6) Increase in Mergers and Acquisitions; 7) Aggressive Pricing Changes in Some Drugs; c) Global Pharmaceutical Drugs Market, 2017, By Segment, Value ($ Billion); 1) Cardiovascular Drugs; 2) Dermatology Drugs; 3) Gastrointestinal Drugs; 3) Gastrointestinal Drugs; 4) Genito-Urinary Drugs; 5) Hematology Drugs; 6) Anti-Infective Drugs; 7) Metabolic Disorders Drugs; 8) Musculoskeletal Disorders Drugs; 9) Central Nervous System Drugs; 10) Oncology Drugs; 11) Ophthalmology Drugs; 12) Respiratory Diseases Drugs; d) Global Pharmaceutical Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.1. Cardiovascular Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Novel Oral Anti-coagulants (NOACs) To Prevent Thrombosis; 2) Approval Of New Drugs For Treatment Of Chronic Heart Failure; 3) Personalized Medicine For Treatment Of Cardiovascular Disorders; 4) Big Data Analytics To Improve Cardiovascular Health; c) Global Cardiovascular Drugs Market, 2017, By Segment, Value ($ Billion); 1) Anti-Hypertensive Drugs; 2) Hypolipidemics; 3) Anti Thrombotics; 4) Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); d) Global Cardiovascular Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.2. Dermatology Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Immune Modulators To Treat Eczema; 2) Genome Testing To Speed Clinical Trials Of Drugs; 3) Increase In Mergers And Acquisitions Activity; 4) Early Rx-To-OTC Switch; 5) Biologics For Dermatology; c) Global Dermatology Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; d) Global Dermatology Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.3. Gastrointestinal Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Tranexamic Acid To Treat Gastrointestinal Bleeding; 2) Increasing R&D Activities; 3) Cost-effective Biosimilars To Treat Gastrointestinal Diseases; c) Global Gastrointestinal Drugs Market, 2017, By Segment, Value ($ Billion); 1) Antacids; 2) Antiulcerants; 3) Vitamin And Minerals; 4) Antiobesity; 5) Antiemetics And Antinauseants; 6) Antidiarrhoeals; d) Global Gastrointestinal Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.4. Genito-Urinary Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Demand For Combination Products; 2) Increasing Demand For Low-Cost Erectile Dysfunction Drugs; 3) Increase In Mergers And Acquisitions; 4) Increase In The Approvals Of Novel Drugs; c) Global Genito-Urinary Drugs Market, 2017, By Segment, Value ($ Billion); 1) Hormonal Contraceptives; 2) Drugs For Benign Prostatic hypertrophy; 3) Drugs For Infertility; 4) Drugs For Erectile Dysfunction; 5) Drugs For Urinary Incontinence And Overactive Bladder; 6) Drugs For Infections And Others; 7) Drugs For Hormonal Replacement Therapy; 8) Diuretics; d) Global Genito-Urinary Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.5. Hematology Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Tranexamic Acid To Prevent Postpartum Hemorrhage; 2) Increase In Product Approvals for Hemophilia; 3) Gene Therapy For Treatment Of Sickle-Cell Disease; 4) Genetically Engineered Drug For Von Willebrand Disease (VWD); c) Global Hematology Drugs Market, 2017, By Segment, Value ($ Billion); 1) Blood Products; 2) Anemia And Other Blood Disorder Drugs; d) Global Hematology Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Hematology Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.6. Anti-Infective Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Strategic Collaborations And Agreements; 3) New Drug Innovations; c) Global Anti-Infective Drugs Market, 2017, By Segment, Value ($ Billion); 1) Antibiotics; 2) Antivirals; 3) Antifungals; 4) Others (Antihelmethic, Antiprotozoal); d) Global Anti-Infective Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.7. Metabolic Disorders Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Strategic Collaborations And Agreements; 2) Demand For New Medicines For Drug-Resistant Infections; 3) New Drug Innovations; c) Global Metabolic Disorders Drugs Market, 2017, By Segment, Value ($ Billion); 1) Development Of New Anti-Diabetic Drugs For Type 2 Diabetes; 2) Enzyme Replacement Therapies For The Treatment Of Of Rare Metabolic Disorders; 3) Increase In Mergers And Acquisitions; d) Global Metabolic Disorders Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.8. Musculoskeletal Disorders Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Acute Musculoskeletal Pain; 2) New Drug Delivery Technologies; 3) Use of Muscle Relaxants in New Indications; c) Global Musculoskeletal Disorders Drugs Market, 2017, By Segment, Value ($ Billion); 1) Drugs For Rheumatoid Arthritis; 2) Muscle Relaxants; 3) Others; d) Global Musculoskeletal Disorders Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.9. Central Nervous System Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Wearables To Improve R&D; 2) Biomarkers In CNS Drug Development; 3) Regenerative Therapies For Central Nervous System Diseases; c) Global Central Nervous System Drugs Market, 2017, By Segment, Value ($ Billion); 1) Nervous System Drugs; 2) Analgesics; 3) Anti-Parkinson drugs; 4) Anaesthetics; 5) Anti-Epileptics; 6) Other CNS drugs; d) Global Central Nervous System Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.10. Oncology Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Collaboration Driving Innovation; 2) Biomarker Driven R&D; 3) Increasing Demand For Personalized Medicines; c) Global Oncology Drugs Market, 2017, By Segment, Value ($ Billion); 1) Lung Cancer; 2) Pancreatic Cancer; 3) Breast Cancer; 4) Prostate Cancer; 5) Ovarian Cancer; 6) Colorectal Cancer; 7) Gastric Cancer; 8) Non-Small Cell Lung Cancer; 9) Kidney Cancer; 10) Brain Tumour; 11) Thyroid Cancer; 12) Skin Cancer; 13) Bladder Cancer; 14) Cervical Cancer; 15) Blood Cancer; 16) Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma); d) Global Oncology Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Oncology Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.11. Ophthalmology Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Rho-Kinase Inhibitors In Glaucoma Treatment; 2) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Dry Eye Treatment; 3) Development Of Combination Therapies; c) Global Ophthalmology Drugs Market, 2017, By Segment, Value ($ Billion); 1) Antiglaucoma Drugs; 2) Dry Eye Medication; 3) Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); d) Global Ophthalmology Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.2.12. Respiratory Diseases Drugs; a) Market Characteristics; b) Market Trends And Strategies; 1) Growing Demand For Tamper-Resistant Pseudoephedrine (PSE) Products; 2) Resurgence Of Nasal Remedies For Treatment Of Cold; 3) Development Of RMC-1 Drug For Respiratory Diseases Treatment; 4) Collaborations In The Respiratory Diseases Drugs Market; c) Global Respiratory Diseases Drugs Market, 2017, By Segment, Value ($ Billion); 1) Anti-Asthmatics And COPD Drugs; 2) Cough And Cold Preparations; d) Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3. Medical Equipment; a) Market Characteristics; b) Market Trends And Strategies; 1) Self-Diagnosis/Treatment is Increasing; 2) Technology and Analytics in Patient Care; 3) Wearables and Mobile Applications; 4) Shift to Service Contracts; c) Global Pharmaceutical Drugs Market, 2017, By Segment, Value ($ Billion); 1) In-Vitro Diagnostics; 2) Dental Equipment And Supplies; 3) Ophthalmic Devices; 4) Diagnostic Equipment; 5) Cardiovascular Devices; 6) Hospital Supplies; 7) Surgical Equipment; 8) Orthopedic Devices; 9) Patient Monitoring Devices; 10) Diabetes Care Devices; 11) Nephrology And Urology Devices; 12) ENT Devices; 13) Anesthesia And Respiratory Devices; 14) Neurology Devices; 15) Wound Care Devices; d) Global Pharmaceutical Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.1. In-Vitro Diagnostics; a) Market Characteristics; b) Market Trends And Strategies; 1) Strategic Collaborations And Agreements; 2) New Product Launches; 3) Rising Demand for Point-of-Care (POC) Testing; c) Global In-Vitro Diagnostics Drugs Market, 2017, By Segment, Value ($ Billion); 1) Point-of-Care Diagnostics; 2) Immunochemistry; 3) Clinical Chemistry Diagnostics Devices; 4) Molecular Diagnostics; 5) Microbiology; 6) Hemostasis; 7) Hematology; 8) Immunohematology; d) Global In-Vitro Diagnostics Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global In-Vitro Diagnostics Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.2. Dental Equipment And Supplies; a) Market Characteristics; b) Market Trends And Strategies; 1) Development Of 3D Printer Implants; 2) Advanced Robotic-Assisted Surgery To Perform Complex Dental Surgeries; 3) Growing Demand For Cosmetic Dentistry; c) Global Dental Equipment And Supplies Drugs Market, 2017, By Segment, Value ($ Billion); 1) Therapeutic Dental Equipment; 2) General Dental Equipment; 3) Dental Diagnostic Imaging Equipment; 4) Dental Surgical Equipment; d) Global Dental Equipment And Supplies Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Dental Equipment And Supplies Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.3. Ophthalmic Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Emergence Of Robotic-Assisted Eye Surgery; 2) Strategic Investments in R&D; 3) Combination Technologies; 4) Development of Drug-Dispensing Contact Lens; c) Global Ophthalmic Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Vision Care Devices; 2) Cataract Surgery Devices; 3) Refractive Surgery Devices; 4) Diagnostic And Monitoring Ophthalmic Devices; d) Global Ophthalmic Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Ophthalmic Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.4. Diagnostic Equipment; a) Market Characteristics; b) Market Trends And Strategies; 1) Increasing Demand For Portable Diagnostic Equipment; 2) Strategic Collaborations And Agreements; 3) New Product Launches; c) Global Diagnostic Equipment Drugs Market, 2017, By Segment, Value ($ Billion); 1) X-Ray Systems; 2) Ultrasound Systems; 3) Computed Tomography (CT) Scanners; 4) Magnetic Resonance Imaging Systems; 5) Cardiovascular Monitoring And Diagnostic Devices; 6) Nuclear Imaging Device; d) Global Diagnostic Equipment Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Diagnostic Equipment Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.5. Cardiovascular Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Increasing Demand For Portable Cardiovascular Devices; 2) Technological Innovations; 3) Increasing Demand for Minimally-Invasive Cardiac Surgeries; 4) Wearable Technology; 5) Growing Demand For Total Artificial Heart (TAH); 6) 3-D Printed Heart Replica; c) Global Cardiovascular Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) X-Ray Systems; 2) Cardiovascular Surgery Devices; 3) Cardiac Rhythm Management (CRM) Devices; 4) Interventional Cardiology Devices; 5) Defibrillator Devices; 6) Peripheral Vascular Devices; 7) Prosthetic Heart Valve Device; 8) Electrophysiology Devices; 9) Cardiac Assist Devices; d) Global Cardiovascular Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Cardiovascular Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.6. Hospital Supplies; a) Market Characteristics; b) Market Trends And Strategies; 1) Technological Innovations In Hospital Beds; 2) Advances in Patient Mobility Aids; 3) Disposable Hospital Supplies; 4) Transforming Supply Chain; c) Global Hospital Supplies Drugs Market, 2017, By Segment, Value ($ Billion); 1) Disposable Hospital Supplies; 2) Sterilization Equipment And Disinfectants; 3) Mobility Aids And Transportation Equipment; 4) Operating Room Equipment; d) Global Hospital Supplies Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Hospital Supplies Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.7. Surgical Equipment; a) Market Characteristics; b) Market Trends And Strategies; 1) Modern Electrosurgical Units (ESUs); 2) Next Generation Ultrasonic Surgical Devices; 3) Advanced Robotic-assisted Surgery; 4) Pay Per Use Model; c) Global Surgical Equipment Drugs Market, 2017, By Segment, Value ($ Billion); 1) Surgical Sutures And Staples; 2) Handheld Surgical Devices; 3) Electrosurgical Devices; d) Global Surgical Equipment Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Surgical Equipment Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.8. Orthopedic Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Introduction of Biodegradable Implants; 2) Development of 3D Printer Implants; 3) Advanced Robotic-Assisted Surgery to Perform Complex Surgeries; 4) Strategic Initiatives; 5) New Product Launches; c) Global Orthopedic Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Joint Reconstruction; 2) Spinal Surgery; 3) Trauma Fixation; 4) Orthrobiologics; 5) Arthroscopy; 6) Orthopedic Braces And Support; 7) Craniomaxillofacial (CMF) Devices; 8) Orthopedic Prosthetics; 9) Orthopedic Accessories (includes Orthopedic Reamers); d) Global Orthopedic Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Orthopedic Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.9. Patient Monitoring Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Introduction of Biodegradable Implants; 2) Customized Multi-parameter Monitors (MPMs); 3) Medical Body Area Network (MBAN); 4) Wearables and Mobile Applications; 5) High Deal Activities; c) Global Patient Monitoring Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Fetal And Neonatal Monitoring Devices; 2) Weight Monitoring And Body Temperature Monitoring Devices; 3) Vital Parameter monitoring devices; 4) Remote Patient Monitoring Devices; d) Global Patient Monitoring Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Patient Monitoring Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.10. Diabetes Care Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Introduction of Biodegradable Implants; 2) Artificial Pancreas; 3) Shift in Traditional Insulin Syringe; 4) Wearable and Mobile Glucose Monitoring Systems; 5) Intelligent Glucose Meters; c) Global Diabetes Care Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Blood Glucose Test Strips; 2) Insulin Pens, Syringes, Pumps And Injectors; 3) Lancing Devices; 4) Continuous Glucose Monitoring Devices; 5) Blood Glucose Meters; d) Global Diabetes Care Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Diabetes Care Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.11. Nephrology And Urology Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Wearable Artificial Kidney; 2) Development of Minimally Invasive Treatments; 3) Development of Lithotripters; c) Global Nephrology And Urology Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Dialysis Devices; 2) Urinary Stone Treatment Devices; 3) Urinary Incontinence & Pelvic Organ Prolapse Devices; 4) Benign Prostatic Hyperplasia (BPH) Treatment Devices; 5) Endoscopy Devices; d) Global Nephrology And Urology Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Nephrology And Urology Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.12. ENT Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Technological Advancements in Otolaryngology; 2) Customized Hearing Implants or 3D Printing; 3) Minimally Invasive Techniques Using Robotic Instruments; c) Global ENT Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Hearing Aid Devices; 2) Hearing Diagnostic Devices; 3) ENT Surgical Devices; 4) Hearing Implants; 5) Voice Prosthesis Devices; 6) Nasal Splints; d) Global ENT Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global ENT Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.13. Anesthesia And Respiratory Devices; a) Market Characteristics; b) Market Trends And Strategies; b) Market Trends And Strategies; 1) Wearable Artificial Kidney; 2) Development of Minimally Invasive Treatments; 3) Development of Lithotripters; c) Global Nephrology And Urology Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Dialysis Devices; 2) Urinary Stone Treatment Devices; 3) Urinary Incontinence & Pelvic Organ Prolapse Devices; 4) Benign Prostatic Hyperplasia (BPH) Treatment Devices; 5) Endoscopy Devices; d) Global Nephrology And Urology Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Nephrology And Urology Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.12. ENT Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Technological Advancements in Otolaryngology; 2) Customized Hearing Implants or 3D Printing; 3) Minimally Invasive Techniques Using Robotic Instruments; c) Global ENT Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Hearing Aid Devices; 2) Hearing Diagnostic Devices; 3) ENT Surgical Devices; 4) Hearing Implants; 5) Voice Prosthesis Devices; 6) Nasal Splints; d) Global ENT Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global ENT Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.13. Anesthesia And Respiratory Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) New Product Launches; 2) Portable Sleep Apnea Diagnostic Devices at Home; 3) Increased Adoption of Portable Systems; c) Global Anesthesia And Respiratory Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Respiratory Devices (Therapeutic And Diagnostic); 2) Anesthesia Machines; 3) Anesthesia Disposables; 4) Respiratory Disposables; d) Global Anesthesia And Respiratory Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Anesthesia And Respiratory Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.14. Neurology Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Wearable Technology; 2) Minimally Invasive Treatments; 3) Increasing M&A activity; c) Global Neurology Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Cerebrospinal Fluid Management (CSF) Devices; 2) Interventional Neurology; 3) Neurosurgery Devices; 4) Neurostimulation Devices; d) Global Neurology Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Neurology Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.3.15. Wound Care Devices; a) Market Characteristics; b) Market Trends And Strategies; 1) Increasing Demand for Combination Dressing; 2) Growing Demand or Anti-Infective Dressings; 3) New Product Launches; 4) Strategic Mergers and Acquisitions; c) Global Wound Care Devices Drugs Market, 2017, By Segment, Value ($ Billion); 1) Cerebrospinal Fluid Management (CSF) Devices; 2) Traditional Adhesive Dressings; 3) Negative-pressure Wound Therapy (NPWT); 4) Traditional Gauze Dressings; 5) Advanced Wound Care Devices; d) Global Wound Care Devices Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Wound Care Devices Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.4. Biologics; a) Market Characteristics; b) Market Trends And Strategies; 1) Demand For Biologics In The Treatment Of Complex Diseases; 2) Increasing Demand For Antibody Drug Conjugates (ADCs); 3) Development Of Next Generation Biologics; 4) Revised FDA Approvals To Facilitate Biologics Drug Development; c) Global Pharmaceutical Drugs Market, 2017, By Segment, Value ($ Billion); 1) Monoclonal Antibodies (MAbS); 2) Therapeutic Proteins; 3) Vaccines; d) Global Pharmaceutical Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.4.1. Monoclonal Antibodies (MAbS); a) Market Characteristics; b) Market Trends And Strategies; c) Global Monoclonal Antibodies (MAbS) Market, 2017, By Segment, Value ($ Billion); 9) Anti-Cancer; 10) Immunological; 11) Anti-Infective; 12) Neuropharmacological; 13) Cardiovascular And Cerebrovascular; 14) Others; d) Global Monoclonal Antibodies (MAbS) Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Monoclonal Antibodies (MAbS) Market, Growth And Market Share Comparison, By Segment; 8.1.4.2. Therapeutic Proteins; a) Market Characteristics; b) Market Trends And Strategies; c) Global Therapeutic Proteins Drugs Market, 2017, By Segment, Value ($ Billion); 1) Metabolic Disorders; 2) Cancer; 3) Cardiovascular Diseases; 4) Immunological Disorders; 5) Others; d) Global Therapeutic Proteins Drugs Market, 2013 - 2021, Historic and Forecast, By Segment; e) Global Therapeutic Proteins Drugs Market, Growth And Market Share Comparison, By Segment; 8.1.4.3. Vaccines; a) Market Characteristics; b) Market Trends And Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report